awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36886148-220E8CCA-8518-402B-8495-5E1C403245D9
Q36886148-220E8CCA-8518-402B-8495-5E1C403245D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36886148-220E8CCA-8518-402B-8495-5E1C403245D9
Treatment of stage IIIb/IV non-small cell lung cancer with Pemetrexed plus Oxaliplatin after failure of Erlotinib as second-line treatment
P2860
Q36886148-220E8CCA-8518-402B-8495-5E1C403245D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36886148-220E8CCA-8518-402B-8495-5E1C403245D9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1765c08cee5a75adc8df50d0701e5c1479d841c3
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.